|
Drug prevents dangerous tick diseases
March 20, 2008Lyme disease is the blight of countryside users but it may be prevented with a single injection, according to research published in the Journal of Medical Microbiology.
The US saw nearly 20,000 cases of Lyme disease in 2006 and there are up to 2,000 cases a year in the UK, a figure that is increasing steadily. Now scientists at the Centers for Disease Control and Prevention in Fort Collins, Colorado, USA, have developed an injection that protects against two severe diseases transmitted by tick bites: Lyme disease and Anaplasmosis.
"Along the North-eastern seaboard of the US, ticks are often co-infected with the bacteria that cause Lyme disease and Anaplasmosis," says Dr Nordin Zeidner. "Currently there is no vaccine to protect against either organism. We have shown that a single injection of sustained-release antibiotics can prevent both diseases in mice."
A single dose of doxycycline given orally is only 20-30% effective at preventing these diseases in mice. The researchers found that a new formulation of doxycycline hyclate that is programmed to release the drug over a 20 day period is 100% effective.
"The underlying copolymer formulation has been in use for over 20 years. It has no adverse effect on humans and it can be programmed to release a drug over several weeks to several months," says Dr Zeidner. "We plan to test the doxycycline formulation to develop different release kinetics and delivery methods. For example, a slow release patch could be used in conjunction with current recommended protection against ticks, such as repellents and personal tick checks."
Society for General Microbiology
A single dose of doxycycline given orally is only 20-30% effective at preventing these diseases in mice. The researchers found that a new formulation of doxycycline hyclate that is programmed to release the drug over a 20 day period is 100% effective.
"The underlying copolymer formulation has been in use for over 20 years. It has no adverse effect on humans and it can be programmed to release a drug over several weeks to several months," says Dr Zeidner. "We plan to test the doxycycline formulation to develop different release kinetics and delivery methods. For example, a slow release patch could be used in conjunction with current recommended protection against ticks, such as repellents and personal tick checks."
Society for General Microbiology
Lyme Disease News and Current Lyme Disease Events RSSDiversity among bird populations found to reduce threat of West Nile virus
A biologist and undergraduate student have discovered that what's good for an area's bird population is also good for people living nearby.
Researchers track Lyme disease spirochetes
Microbiologists at the University of Calgary have demonstrated the first direct visualization of the dissemination of Borrelia burgdorferi, the bacterium that causes Lyme disease.
University of Pennsylvania Study Reveals Inconspicuous Hosts in the Lyme Disease Epidemic
A study led by a University of Pennsylvania biologist in the tick-infested woods of the Hudson Valley is challenging the widely held belief that mice are the main animal reservoir for Lyme disease in the U.S.
First placebo-controlled study of cognitive impairment due to chronic Lyme disease
Findings from the first placebo-controlled study of chronic cognitive impairment after treated Lyme disease (also known as chronic Lyme encephalopathy) demonstrate that patients report moderate cognitive impairment, physical dysfunction comparable to patients with congestive heart failure, and fatigue comparable to patients with multiple sclerosis.
Water, air and soil pollution causes 40 percent of deaths worldwide, Cornell research survey finds
About 40 percent of deaths worldwide are caused by water, air and soil pollution, concludes a Cornell researcher. Such environmental degradation, coupled with the growth in world population, are major causes behind the rapid increase in human diseases, which the World Health Organization has recently reported.
"Combination" Lyme Disease Vaccine Proteins Patented
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory and collaborators at Stony Brook University have received U.S. Patent Number 7,179,448 for developing chimeric, or "combination," proteins that may advance the development of vaccines and diagnostic tests for Lyme disease.
Animal testing alternative has ticks trembling at the knees
The thousands of test animals currently required to evaluate new pesticides could be replaced by tricking ticks into setting up home on a faux cow hide.
LIAI scientists identify immune system trigger for fighting Lyme disease
Researchers at the La Jolla Institute for Allergy & Immunology (LIAI) today announced an important finding on Lyme disease that could eventually lead to the development of a new vaccine to prevent this tick-borne disorder.
Infectious disease experts offer advice to prevent and treat lyme disease
It's tick season, but gardeners, hikers, and others enjoying the great outdoors shouldn't let concerns about Lyme disease keep them inside. A few tips to keep ticks away, and some advice from infectious diseases doctors about Lyme disease, should help you enjoy the spring and summer weather.
A new view on Lyme disease: Rodents hold the key to annual risk
In the United States, Lyme disease incidence has skyrocketed from 497 cases reported in 1982 (the first year national statistics were collected) to a record 23,763 in 2002.
More Lyme Disease News Articles
| © 2008 BrightSurf.com |